Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04214886
Title CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Loyola University

B-cell lymphoma

B-cell acute lymphoblastic leukemia


CD19-CD34 CAR transduced T cells + Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.